Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy
Male
Adolescent
Motor Activity
3. Good health
Muscular Dystrophy, Duchenne
03 medical and health sciences
Heart Rate
Case-Control Studies
Child, Preschool
Calibration
Body Composition
Humans
Child
0305 other medical science
DOI:
10.1016/j.apmr.2004.10.012
Publication Date:
2005-04-18T18:21:11Z
AUTHORS (5)
ABSTRACT
To evaluate the StepWatch Activity Monitor (SAM) as a quantitative measure of community ambulation, to investigate activity patterns and heart rate of ambulatory boys with Duchenne muscular dystrophy (DMD), and to correlate the step activity with measures of body composition and strength.Case-control study.General community and laboratory.Sixteen ambulatory boys with DMD and 20 male controls (age range, 5-13 y).Not applicable.Laboratory determinations of body composition, knee extension strength, and minute-by-minute step rate and heart rate during 3 days of community activity.During the 3 days of activity, DMD subjects, when compared with controls, (1) had significantly more inactive minutes (1096+/-90 min/d vs 1028+/-85 min/d), (2) took significantly fewer steps and spent fewer minutes at moderate (66+/-31 min/d vs 94+/-30 min/d) and high step rates (43+/-30 min/d vs 72+/-38 min/d), (3) had higher resting heart rate (110+/-12 beats/min vs 94+/-7 beats/min) and lower increase in heart rate with increased step rate, and (4) had lower maximum heart rates (164+/-24 beats/min vs 208+/-16 beats/min). Percentage of body fat and knee extension strength correlated with total step activity in the DMD group but not in the control group.Step-rate monitoring with the SAM provides useful outcome measures with which to evaluate the activity of ambulatory boys with DMD. Their heart rate did not increase with activity to the same degree as observed in the control group.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (16)
CITATIONS (83)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....